Can school-located vaccination have a major impact on human papilloma virus vaccination rates in the United States?

Articles
Kempe, A., Allison, M. A., & Daley, M. F., (2018). Can school-located vaccination have a major impact on human papilloma virus vaccination rates in the United States? Academic Pediatrics, 18(S2), S101-S105.
School-local vaccination (SLV) has been a highly effective method of increasing rates of human papillomavirus (HPV) vaccination in many countries internationally in which vaccines…

Parents who decline HPV vaccination: Who later accepts and why?

Articles
Kornides, M. L., McRee, A.-L., & Gilkey, M. B., (2018). Parents who decline HPV vaccination: Who later accepts and why? Academic Pediatrics, 18(2S), S37-S43.
Objective: Parental declination contributes to low human papillomavirus (HPV) vaccination coverage among US adolescents, resulting in missed opportunities for cancer prevention. W…

Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: A national register-based cohort study.

Articles
Kreusch, T., Wang, J., Sparen, P., & Sundstrom, K., (2018). Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: A national register-based cohort study. BMJ Open, 8, e024477.
Objectives To investigate whether cervical screening attendance differs between human papillomavirus (HPV) vaccinated and unvaccinated women and to investigate potential underlyin…

Assessment of eight HPV vaccination programs implemented in lowest income countries.

Articles
Ladner, J., Besson, M.-H., Hampshire, R., Tapert, L., Chirenje, M., & Saba, J., (2012). Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health, 12, 370.
Background: Cervix cancer, preventable, continues to be the third most common cancer in women worldwide, especially in lowest income countries. Prophylactic HPV vaccination should…

Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.

Articles
Ladner, J., Besson, M.-H., Rodrigues, M., Audureau, E., & Saba, J., (2014). Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health, 14, 670.
Background: Cervical cancer is the third most common cancer in women worldwide, with high incidence in lowest income countries. Vaccination against Human Papilloma Virus (HPV) may…

Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.

Articles
Ladner, J., Besson, M.-H., Audureau, E., Rodrigues, M., & Saba, J., (2016). Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014. BMC Health Services Research, 16, 575.
Background: Cervical cancer is the greatest cause of age-weighted years of life lost in the developing world. Human papillomavirus (HPV) infection is associated with a high propor…

Influencers and preference predictors of HPV vaccine uptake among US male and female young adult college students.

Articles
LaJoie, A. S., Kerr, J. C., Clover, R. D., & Harper, D. M., (2018). Influencers and preference predictors of HPV vaccine uptake among US male and female young adult college students. Papillomavirus Research, 5, 114-121.
Objective: The purpose of the study was to assess the knowledge, attitudes and beliefs of male and female college students in Kentucky about HPV associated diseases and vaccines, …

Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India.

Articles
Madhivanan, P., Li, T., Srinivas, V., Marlow, L., Mukherjee, S., & Krupp, K., (2014). Human papillomavirus vaccine acceptability among parents of adolescent girls: Obstacles and challenges in Mysore, India. Preventive Medicine, 64, 69-74.
Objective. Worldwide, 530,000 women are diagnosed with cervical cancer and 275,000 die annually. India bears the greatest burden of the disease with 132,000 cases and 74,000 death…

Human papillomavirus vaccine introduction - The first five years.

Articles
Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M. L., (2012). Human papillomavirus vaccine introduction - The first five years. Vaccine, 30S, F139-F148.
The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful tools for primary prevention of cervical cancer and other HPV-associated diseases. Since…

Ten years of human papilloma virus vaccination in the United States.

Articles
Markowitz, L. E., Gee, J., Chesson, H., & Stokley, S., (2018). Ten years of human papilloma virus vaccination in the United States. Academic Pediatrics, 18(2S), S3-S20.
Since human papillomavirus (HPV) vaccine was first introduced for females in the United States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed and…

Virtual Oceania

Introductory Workshop

May 29th - 31st, 2024

Registration Ending Soon!
Learn More

Virtual North America

Introductory Workshop

Jun 3rd - 5th, 2024

Learn More
Site Courtesy of
McKenzie-Mohr & Associates

Expertise in Community-Based Social Marketing